OSIR (Osiris Therapeuti)
All Pro Portfolios with OSIR
All Do-It-Yourself Portfolios with OSIR
- Total Do-It-Yourself Portfolios with OSIR:
- snookz101 Portfolio 1
- Livermore I
- herb's first try
- KenC132000 Portfolio 1
- monroecasey Portfolio 1
- RangerOne
- Siebert
- Playing Stem Cells
- StemCellPlays
- Ptrades
- simbill2 Portfolio 1
- malin420 Portfolio 1
- Insider Biotech Buys
- my dog
- gwen one
- Last Day of the JPMorgan Healtcare Conf.
- Three Medical Obama Plays
- show more
- 34
- Adamantium Partners
- Sunshine
- STEM CELL
- Srfahey Portfolio 1
- m&l's
- Ganderman Portfolio 1
- Barron's Stem Cell Stocks
- phanorg Portfolio 1
- stock3 Portfolio 1
- Mbledug's First
- rentman10
- tgosson Portfolio 1
- mmhood Portfolio 1
- Barron's Insider Purchases 12-29-2007
- Barron's Insider Purchases 7-12-2008
- RAPTOR SPRTD-0203092032
- winners123
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:sfmain |
Date:08 31 09 |
options value |
|
Not yet rated
Rate now:
|
|
Date:01 10 09 |
|
9 |
|
Not yet rated
Rate now:
|
|
By:Dan Jacobs |
Date:01 14 08 |
stem cell / defense /biotech play featured in Investors Business Daily. The company uses adult stem cells to repair GI tract after radiation exposure. |
|
Not yet rated
Rate now:
|
|
By:Dan Jacobs |
Date:01 14 08 |
stem cell / defense /biotech play featured in Investors Business Daily. The company uses adult stem cells to repair GI tract after radiation exposure. |
|
Not yet rated
Rate now:
|
|
By:gman0412 |
Date:12 07 07 |
i think it a good stock,its at the low and got fast |
|
Not yet rated
Rate now:
|
|
By:rentman |
Date:08 23 07 |
news |
|
Not yet rated
Rate now:
|
|
By:Jamie Fitch |
Date:05 17 07 |
Osiris Therapeutics is focusing on using mesenchymal stem cells (MSCs). these cells come from adult bone marrow. They are interesting in that they are not highly specialized and can be converted into a variety of connective tissues using specific enzymes (they are the adult stell cells most similar to embyronic stem cells). Osiris is currently looking to use MSCs to treat inflammatory diseases, heart disease, and to aid in spinal fusions. They already have one product in the market (Osteocel) for spinal fusions. This product helps create the spongy interior of bones and aids in fusion. It is the only stem cell treatment that is on the market (as of Dec 06). Additionally, they have three other products in phase I-III stage clinical trials. This bodes well for the company. While their financials have been ugly of late, at least this company has a treatment on the market. Additionally, research approaching advanced trials on diseases such as Crohn's disease could pay off in the somewhat near future. Finally, it has been able to harbor MSCs to create a wide variety of tissues, much like embryonic cells will be able to do. This makes me believe they will be able to adapt and use the new + presumably more potent cells quickly. They have shown the ability to get a stem cell product to the market, which is extremely challenging. Unlike STEM, this company will rely more on its products and less on its potential to convince investors to back them. They are probably the furthest along of all of companies I will be considering in stem cell therapy techniques. |
|
Not yet rated
Rate now:
|
|
By:Barrons |
Date:05 05 07 |
"Provacel stem-cell treatment for heart disease." |
|
Not yet rated
Rate now:
|
|
By:mldillon |
Date:04 18 07 |
BSR pick, mesenchymal cell technology, clinical therapeutic trials |
|
Not yet rated
Rate now:
|
|
By:Calculatorci |
Date:04 09 07 |
Stem Cell,Cardiac Play |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
By:rnaia |
Date:09 05 09 |
LOSS |
|
Not yet rated
Rate now:
|
|
